These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37509540)

  • 41. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
    Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
    Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology.
    Zielińska A; Carreiró F; Oliveira AM; Neves A; Pires B; Venkatesh DN; Durazzo A; Lucarini M; Eder P; Silva AM; Santini A; Souto EB
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32824172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study.
    Navarro-Partida J; Altamirano-Vallejo JC; Lopez-Naranjo EJ; Gonzalez-De la Rosa A; Manzano-Ramírez A; Apatiga-Castro LM; Armendáriz-Borunda J; Santos A
    J Ocul Pharmacol Ther; 2020; 36(6):393-403. PubMed ID: 32564664
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapies Based on Nanoparticles for Eye Drug Delivery.
    Meza-Rios A; Navarro-Partida J; Armendariz-Borunda J; Santos A
    Ophthalmol Ther; 2020 Sep; 9(3):1-14. PubMed ID: 32383107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.
    Yeh S; Khurana RN; Shah M; Henry CR; Wang RC; Kissner JM; Ciulla TA; Noronha G;
    Ophthalmology; 2020 Jul; 127(7):948-955. PubMed ID: 32173113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity.
    Nirbhavane P; Sharma G; Singh B; Begum G; Jones MC; Rauz S; Vincent R; Denniston AK; Hill LJ; Katare OP
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110902. PubMed ID: 32143010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticosteroids for Diabetic Macular Edema.
    Chawan-Saad J; Wu M; Wu A; Wu L
    Taiwan J Ophthalmol; 2019; 9(4):233-242. PubMed ID: 31942428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.
    Karasu B
    Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases.
    Khalil M; Hashmi U; Riaz R; Rukh Abbas S
    Int J Biol Macromol; 2020 Jan; 143():483-491. PubMed ID: 31759018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
    Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
    Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
    Cheng T; Li J; Cheng Y; Zhang X; Qu Y
    Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents.
    Souto EB; Dias-Ferreira J; López-Machado A; Ettcheto M; Cano A; Camins Espuny A; Espina M; Garcia ML; Sánchez-López E
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31500106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery.
    Gonzalez-De la Rosa A; Navarro-Partida J; Altamirano-Vallejo JC; Jauregui-Garcia GD; Acosta-Gonzalez R; Ibanez-Hernandez MA; Mora-Gonzalez GF; Armendáriz-Borunda J; Santos A
    J Ocul Pharmacol Ther; 2019 Nov; 35(9):512-521. PubMed ID: 31486694
    [No Abstract]   [Full Text] [Related]  

  • 54. Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study.
    Campochiaro PA; Wykoff CC; Brown DM; Boyer DS; Barakat M; Taraborelli D; Noronha G;
    Ophthalmol Retina; 2018 Apr; 2(4):320-328. PubMed ID: 31047241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melt-Cast Films Significantly Enhance Triamcinolone Acetonide Delivery to the Deeper Ocular Tissues.
    Tatke A; Dudhipala N; Janga KY; Soneta B; Avula B; Majumdar S
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30987011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye.
    Li J; Cheng T; Tian Q; Cheng Y; Zhao L; Zhang X; Qu Y
    Drug Deliv; 2019 Dec; 26(1):188-198. PubMed ID: 30835587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.
    Gonzalez-De la Rosa A; Navarro-Partida J; Altamirano-Vallejo JC; Hernandez-Gamez AG; Garcia-Bañuelos JJ; Armendariz-Borunda J; Santos A
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):106-115. PubMed ID: 30614750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies.
    Tatke A; Dudhipala N; Janga KY; Balguri SP; Avula B; Jablonski MM; Majumdar S
    Nanomaterials (Basel); 2018 Dec; 9(1):. PubMed ID: 30591688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
    Storey PP; Obeid A; Pancholy M; Goodman J; Borkar D; Su D; Regillo C
    Retina; 2020 Jan; 40(1):75-79. PubMed ID: 30308561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
    Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
    Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.